ARCHIVES

Talactoferrin Second-Line Therapy Increases Survival In Stage IIIB/IV

This article is from The Cancer Letter archive.

Vol. 34 No. 10 | October 28, 2011

Download PDF Visit The Full Archive

Related Articles

1998 Cancer Meetings Listed Through Oct.

January 9, 1998

ODAC Votes 10-0 In Favor Of Avastin For Recurrent Glioblastoma Multiforme

April 3, 2009

Consensus Growing On Prevention Strategies: Higginson

August 14, 1981

Congressional Report Says NCI Ignored Das, Procedure, In Charges To Screening Guidelines

November 4, 1994

In Brief: Urologist Appointed To NCAB; Stovall Named To US Pharmacopeia Oncology Advisory Panel

September 8, 1995

“I Can’t Permit Destruction of NSABP,” Fisher Writes

September 9, 1994